TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32885995

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 9007

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 9007

Group type: EXPERIMENTAL
Intervention: Non-steroid anti-inflammatory drugs (NSAIDs)
Number of subjects: 9007

Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 9007
Study: 33113886

Group type: EXPERIMENTAL
Intervention: Combination of spicule technique and nail brace with a polyethylene plastic strip
Number of subjects: 94

Group type: COMPARATOR
Intervention: Spicule technique alone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Nail brace technique
Number of subjects: 94
Study: 36443282

Group type: EXPERIMENTAL
Intervention: Prednisolone 40 mg daily for 1 week, then 20 mg daily for 1 week, then 10 mg daily for 1 week, plus NSAID for 3 weeks
Number of subjects: 40
Study: 36082522

Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 300

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 300
Study: 33635385

Group type: EXPERIMENTAL
Intervention: Low-dose alcohol (0.4 g kg−1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose alcohol (0.8 g kg−1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32223849

Group type: EXPERIMENTAL
Intervention: Modified pedometer-based Green Prescription
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard time-based Green Prescription
Number of subjects: 330
Study: 33179859

Group type: EXPERIMENTAL
Intervention: Down syndrome group (DS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (matched by age and gender)
Number of subjects: 22
Study: 34068000

Group type: EXPERIMENTAL
Intervention: NRT_N0G5IJ
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32207984

Group type: EXPERIMENTAL
Intervention: Wendan decoction (WDD) administered three times daily for more than 1 month, initiated within 14 days of injury.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional neurologic intensive care (Control group).
Number of subjects: 60
Study: 35749349

Group type: EXPERIMENTAL
Intervention: Motor control exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: General exercises
Number of subjects: 60
Study: 32554693

Group type: EXPERIMENTAL
Intervention: Thrombectomy with TICI 2b-3 revascularization
Number of subjects: 70
Study: 32977013

Group type: EXPERIMENTAL
Intervention: Minimally invasive segmentectomy (MIS)
Number of subjects: 683

Group type: COMPARATOR
Intervention: Open segmentectomy
Number of subjects: 683
Study: 34911041

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 32359367

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (0.9% saline)
Number of subjects: 46
Study: 35876008

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with magnesium, phosphate, omega 6 (linoleic acid calcium salt), and omega 7 (palmitoleic acid calcium salt)
Number of subjects: 532

Group type: COMPARATOR
Intervention: Isotretinoin (13-cis retinoic acid)
Number of subjects: 532
Study: 34242265

Group type: EXPERIMENTAL
Intervention: network-based approach for drug target indication expansion
Number of subjects: 15
Study: 32561827

Group type: EXPERIMENTAL
Intervention: Atrazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tribenuron-methyl
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Herbicide doses less than the recommended field application concentration (RFAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blank control
Number of subjects: 0
Study: 34453952

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Control (fellow eye without LPI)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: LPI
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Older participants
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Higher baseline IOP
Number of subjects: 480
Study: 33909773

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32412097

Group type: EXPERIMENTAL
Intervention: ECT plus agomelatine 50 mg/day (n = 48)
Number of subjects: 97

Group type: COMPARATOR
Intervention: ECT plus placebo (n = 49)
Number of subjects: 97
Study: 35641603

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) injection
Number of subjects: 78

Group type: COMPARATOR
Intervention: Limited fasciectomy (Surgery)
Number of subjects: 78
Study: 33417876

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 200
Study: 32407901

Group type: EXPERIMENTAL
Intervention: Cefuroxime + roxithromycin
Number of subjects: 84

Group type: COMPARATOR
Intervention: Ampicillin + roxithromycin
Number of subjects: 84
Study: 37441289

Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance for interscalene block with 15 ml 0.5% bupivacaine and 5 ml 2% lignocaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nerve stimulator (NS) guidance for interscalene block with 15 ml 0.5% bupivacaine and 5 ml 2% lignocaine
Number of subjects: 100
Study: 33998334

Group type: EXPERIMENTAL
Intervention: Peer influence on handwashing behavior; 72% of children would wash hands if their friends were also washing hands.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Perception of illness threat; >91% of children had low illness threat perception.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Visual proof of germs; 46% of children cited inability to see germs as a barrier to handwashing.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Sources of information; Family, teachers, and peers were identified as the most important sources of information.
Number of subjects: 106
Study: 36293867

Group type: EXPERIMENTAL
Intervention: KDL Active School Plan (KDL‐ASP)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Conventional physical activities
Number of subjects: 596
Study: 34495283

Group type: EXPERIMENTAL
Intervention: POINT group (opt-in narcotic treatment)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (routine narcotic prescriptions)
Number of subjects: 102
Study: 36104820

Group type: EXPERIMENTAL
Intervention: Combined cognitive‐motor telerehabilitation programme
Number of subjects: 90

Group type: COMPARATOR
Intervention: Only cognitive training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Only motor training
Number of subjects: 90
Study: 33547218

Group type: EXPERIMENTAL
Intervention: Sucroferric oxyhydroxide
Number of subjects: 160

Group type: COMPARATOR
Intervention: Lanthanum carbonate
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Strict phosphate target range (3.5-4.5 mg/dl)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard phosphate target range (5.0-6.0 mg/dl)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Strict phosphate control
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Older participants (aged 65-74 years)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Younger participants (aged 20-64 years)
Number of subjects: 160
Study: 33420277

Group type: EXPERIMENTAL
Intervention: 20 Hz WBV intervention program
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 30 Hz WBV intervention program
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 84
Study: 33371172

Group type: EXPERIMENTAL
Intervention: Modular transitional nursing intervention
Number of subjects: 80
Study: 35430119

Group type: EXPERIMENTAL
Intervention: Day-5 embryo transfer (blastocyst stage)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Day-3 embryo transfer (cleavage stage)
Number of subjects: 134
Study: 34070736

Group type: EXPERIMENTAL
Intervention: School-based interventions
Number of subjects: 2202
Study: 32138712

Group type: EXPERIMENTAL
Intervention: OptiBIRTH intervention (evidence-based education of clinicians and women, appointment of opinion leaders, audit/peer review, joint discussions)
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 2002

Group type: EXPERIMENTAL
Intervention: OptiBIRTH intervention
Number of subjects: 2002

Group type: COMPARATOR
Intervention: Control
Number of subjects: 2002

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 2002
Study: 35882541

Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Human metapneumovirus (hMPV)
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Human rhinovirus/enterovirus (HRV/EV)
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Parainfluenza
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Atypical bacterial pathogens
Number of subjects: 931
Study: 33040439

Group type: EXPERIMENTAL
Intervention: Dual therapy (esomeprazole 20 mg and amoxicillin 750 mg four times daily)
Number of subjects: 760

Group type: COMPARATOR
Intervention: Triple plus bismuth (TPB) therapy (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, and bismuth potassium citrate 220 mg twice daily)
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Dual therapy
Number of subjects: 760

Group type: COMPARATOR
Intervention: TPB therapy
Number of subjects: 760
Study: 36156799

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MedD)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Western diet (Control group)
Number of subjects: 37
Study: 33119491

Group type: EXPERIMENTAL
Intervention: Active tDCS (1.5 mA for 20 minutes)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 33
Study: 33294804

Group type: EXPERIMENTAL
Intervention: Landiolol plus conventional sepsis therapy
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional sepsis therapy alone (control group)
Number of subjects: 151
Study: 34949538

Group type: EXPERIMENTAL
Intervention: 20-mg hyoscine butylbromide (HBB)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 111
Study: 36183113

Group type: EXPERIMENTAL
Intervention: Alum-adjuvanted rabies vaccine (ARV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-adjuvanted rabies vaccine (NRV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33834520

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0
Study: 33183662

Group type: EXPERIMENTAL
Intervention: Carrot seed (500 mg three times a day for 12 weeks)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 36315128

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily after a 1-month phase of 40 mg daily
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 32787361

Group type: EXPERIMENTAL
Intervention: Prolong life with nine turn method (PLWNT) Qigong
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 90
Study: 32078503

Group type: EXPERIMENTAL
Intervention: Intervention centers with hydration stations, water testing services, reusable water bottles, and water promotion and education training
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intervention centers
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intervention sites
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control centers
Number of subjects: 28
Study: 32711943

Group type: EXPERIMENTAL
Intervention: Newly designed oblique stabilizers
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard perpendicular stabilizers
Number of subjects: 30
Study: 32497261

Group type: EXPERIMENTAL
Intervention: Induction-concurrent sequence (induction-PX regimen)
Number of subjects: 803

Group type: COMPARATOR
Intervention: Induction-PX regimen
Number of subjects: 803

Group type: COMPARATOR
Intervention: Concurrent-adjuvant sequence
Number of subjects: 803

Group type: COMPARATOR
Intervention: Adjuvant-PF regimen
Number of subjects: 803

Group type: COMPARATOR
Intervention: Accelerated-fractionation group
Number of subjects: 803

Group type: COMPARATOR
Intervention: 3-arm chemotherapy cohort
Number of subjects: 803
Study: 36472596

Group type: EXPERIMENTAL
Intervention: Receptivity-timed frozen embryo transfer (n=381) with adjusted duration of progesterone exposure if indicated by receptivity testing.
Number of subjects: 767

Group type: COMPARATOR
Intervention: Standard timing frozen embryo transfer (n=386) regardless of receptivity test results.
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Receptivity-timed frozen embryo transfer (n=381)
Number of subjects: 767

Group type: COMPARATOR
Intervention: Standard timing frozen embryo transfer (n=386)
Number of subjects: 767
Study: 35737597

Group type: EXPERIMENTAL
Intervention: Palmitoylethanolamide (PEA) 600 mg plus lithium and risperidone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 33059108

Group type: EXPERIMENTAL
Intervention: Violet LED
Number of subjects: 70

Group type: COMPARATOR
Intervention: HP 35% without light activation
Number of subjects: 70

Group type: COMPARATOR
Intervention: CP 16% for 4 h/day without light activation
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: HP 35% + violet LED
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CP 16% for 4 h/day + violet LED
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: HP 35% without light activation + CP 16% for 4 h/day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Artificial saliva (placebo)
Number of subjects: 70
Study: 33989767

Group type: EXPERIMENTAL
Intervention: Novel immuno-oncology drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sensitivity analyses using methods suitable under non-proportional hazards (non-PH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial design and sample size calculation methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methods for conducting sensitivity analyses for overall survival (OS)
Number of subjects: 0
Study: 33538790

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus GnRHa
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: AI plus GnRHa
Number of subjects: 56
Study: 34059016

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)‐based counseling, six in‐person sessions and two telephone sessions once per week after the 14th week of pregnancy.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Routine care (control group).
Number of subjects: 56
Study: 32779610

Group type: EXPERIMENTAL
Intervention: Self-expanding drug-eluting stent (DES) with a 1-mm larger diameter than the reference vessel diameter
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-expanding drug-eluting stent (DES) with a 2-mm larger diameter than the reference vessel diameter
Number of subjects: 40
Study: 34213746

Group type: EXPERIMENTAL
Intervention: Patients with AN
Number of subjects: 66

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 66
Study: 33913339

Group type: EXPERIMENTAL
Intervention: Denosumab (60 mg every 6 months)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Alendronic acid (70 mg once weekly)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 150
Study: 34677080

Group type: EXPERIMENTAL
Intervention: Robotic vessel sealer
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard PLND using clips
Number of subjects: 120
Study: 32473865

Group type: EXPERIMENTAL
Intervention: Mepilex Border Post-Op
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aquacel Surgical
Number of subjects: 0
Study: 34487750

Group type: EXPERIMENTAL
Intervention: Saroglitazar 4 mg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Saroglitazar 2 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 34111832

Group type: EXPERIMENTAL
Intervention: Adequate fruit and vegetable intake (at least twice daily or a combination of at least five times daily)
Number of subjects: 7576

Group type: EXPERIMENTAL
Intervention: High protein food consumption (at least twice weekly)
Number of subjects: 7576

Group type: EXPERIMENTAL
Intervention: Not consuming fast foods in the past week
Number of subjects: 7576

Group type: EXPERIMENTAL
Intervention: Not consuming carbonated/sweetened drinks in the past 30 days
Number of subjects: 7576
Study: 32679281

Group type: EXPERIMENTAL
Intervention: Tongxinluo (TXL)
Number of subjects: 3796

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3796
Study: 32209913

Group type: EXPERIMENTAL
Intervention: Qualitative study based on semi-structured phone interviews with severe trauma survivors.
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of trauma survivors' experiences.
Number of subjects: 340
Study: 32434761

Group type: EXPERIMENTAL
Intervention: Eliminating the Stigma of Differences (ESD)
Number of subjects: 416

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 416

Group type: COMPARATOR
Intervention: Comparator interventions (contact with young adults with mental illness and exposure to antistigma printed materials)
Number of subjects: 416
Study: 32610815

Group type: EXPERIMENTAL
Intervention: Public meetings and elections
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Elections for governance committee members
Number of subjects: 10
Study: 34092603

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation and instrument-assisted soft tissue mobilization combined treatment (TICT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 36172716

Group type: EXPERIMENTAL
Intervention: Home hand therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 105
Study: 33929389

Group type: EXPERIMENTAL
Intervention: Metformin (2, 5, 10, and 20 mmol/L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hypoxia
Number of subjects: 0

Group type: COMPARATOR
Intervention: siPrkaa1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control small interfering RNA
Number of subjects: 0
Study: 32389532

Group type: EXPERIMENTAL
Intervention: Intervention group (24 weeks of hour-long, twice-weekly classes including strength training, aerobic exercise, nutrition education, and civic engagement activities)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (delayed intervention, received the program after 24-week outcome assessment)
Number of subjects: 182
Study: 35405991

Group type: EXPERIMENTAL
Intervention: Wine (27 g of alcohol/day for 8 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Ethanol (27 g of alcohol/day for 8 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: No alcohol (control group)
Number of subjects: 64
Study: 32620174

Group type: EXPERIMENTAL
Intervention: Non-invasive oscillating device (NIOD) for chest physiotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard chest physiotherapy (CPT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: NIOD
Number of subjects: 50

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 50
Study: 33184627

Group type: EXPERIMENTAL
Intervention: Energy deficit (DEF) at 45% of total daily energy expenditure
Number of subjects: 10

Group type: COMPARATOR
Intervention: Energy matched (BAL) to individual estimated total daily energy expenditure (±10%)
Number of subjects: 10
Study: 35468458

Group type: EXPERIMENTAL
Intervention: Simulation problem-based learning for cesarean section maternity nursing
Number of subjects: 93

Group type: COMPARATOR
Intervention: Conventional type of maternity nursing clinical practice
Number of subjects: 93
Study: 32460241

Group type: EXPERIMENTAL
Intervention: NZBC extract (600 mg/day for 7 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34954585

Group type: COMPARATOR
Intervention: Laser posterior cordotomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined laser posterior cordotomy with suture lateralization
Number of subjects: 40
Study: 34762376

Group type: EXPERIMENTAL
Intervention: Abdominal acupoint thread embedding therapy combined with donepezil hydrochloride tablets (5 mg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Donepezil hydrochloride tablets (5 mg per day)
Number of subjects: 60
Study: 32389658

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy (110 mg or 150 mg twice daily)
Number of subjects: 2725

Group type: COMPARATOR
Intervention: Warfarin triple therapy (warfarin, aspirin, and a P2Y12 platelet inhibitor)
Number of subjects: 2725

Group type: EXPERIMENTAL
Intervention: Dabigatran dual therapy
Number of subjects: 2725

Group type: COMPARATOR
Intervention: Warfarin triple therapy
Number of subjects: 2725
Study: 35611667

Group type: EXPERIMENTAL
Intervention: Synbiotic containing Lactobacillus paracasei DKGF1 and Opuntia humifusa, administered once a day for 4 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo, administered once a day for 4 weeks
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 33934443

Group type: EXPERIMENTAL
Intervention: Silymarin with Fingolimod (FTY720)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo with Fingolimod (FTY720)
Number of subjects: 48
Study: 33386898

Group type: EXPERIMENTAL
Intervention: adalimumab plus methotrexate
Number of subjects: 180

Group type: COMPARATOR
Intervention: placebo plus methotrexate
Number of subjects: 180
Study: 34352125

Group type: EXPERIMENTAL
Intervention: Triangular neck (TN) implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: Round neck (RN) implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both TN and RN implants
Number of subjects: 20
Study: 33278083

Group type: EXPERIMENTAL
Intervention: Air inflation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Optisol GS storage media
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PDEK bubbling
Number of subjects: 25
Study: 32077550

Group type: EXPERIMENTAL
Intervention: Anlotinib
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 437
Study: 35168964

Group type: EXPERIMENTAL
Intervention: Healthy food prescription incentive (n=297) with a weekly incentive of CDN$10.50/household member for 6 months
Number of subjects: 594

Group type: COMPARATOR
Intervention: Healthy food prescription comparison group (n=297)
Number of subjects: 594